Literature DB >> 17110014

Proteolytic processing by matrix metalloproteinases and phosphorylation by protein kinase CK2 of fetuin-A, the major globulin of fetal calf serum.

Dieter Kübler1, Darko Gosenca, Mathias Wind, Hans Heid, Ilan Friedberg, Willi Jahnen-Dechent, Wolf D Lehmann.   

Abstract

Bovine fetuin-A is a member of a glycoprotein family with a wide spectrum of functions. Until now the bovine protein has been thought to be a single-chain protein. Recently we have shown that native bovine plasma fetuin-A partially exists as a disulfide-bridged two-chain protein with a heavy N-terminal and a lighter C-terminal chain similar to the structure of human fetuin-A homologue (alpha2HS glycoprotein), and also is partially phosphorylated at residues Ser120, Ser302, Ser305 and Ser306 (Wind et al., Anal. Biochem. 317 (2003) 26-33). Both fetuin-A modifications, the phosphorylation at the four sites as well as the proteolysis which causes longer or shorter light chains (termed lc-1 and lc-2, respectively), are probably brought about by targeted enzymatic activities which still need to be defined. In this study we show that authentic bovine fetuin-A disulfide-bridged two-chain forms, which include the original C-terminus, were liberated from the single-chain precursor by metalloproteinases MMP-3 (stromelysin-1) and MMP-7 (matrilysin), but not by elastase, cathepsin E and cathepsin G. Peptide sequencing suggested cleavage sites chiefly at the Pro277-Ser278 or Arg294-His295 peptide bonds. Fetuin-A radioactive phosphorylation in vitro by protein kinase CK2 caused (32)P incorporation into the fetuin-A light chain lc-1 but not lc-2 or the fetuin-A heavy chain, as revealed by MMP assisted proteolysis. Analysis by nanoESI-MS pinpointed phosphorylation at the native phospho-residues Ser302, Ser305 and Ser306 by increased relative abundance following in vitro phosphorylation. Moreover, CK2 phosphorylation of synthetic C-terminal fetuin-A peptides, used as effective controls to the native protein, strongly implies that CK2 is involved in the in vivo phosphorylation of fetuin-A. The phosphorylation of N-terminally truncated peptide homologs seemed highly dependent on the sequence context N-terminal of the phosphorylation sites, thus providing a likely explanation for the non-phosphorylation of the light chain lc-2 in native fetuin-A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110014     DOI: 10.1016/j.biochi.2006.10.012

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  Susceptibility of different proteins to flow-induced conformational changes monitored with Raman spectroscopy.

Authors:  Lorna Ashton; Jonathan Dusting; Eboshogwe Imomoh; Stavroula Balabani; Ewan W Blanch
Journal:  Biophys J       Date:  2010-02-17       Impact factor: 4.033

Review 2.  Tissue chaperoning-the expanded functions of fetuin-A beyond inhibition of systemic calcification.

Authors:  Stefan Rudloff; Willi Jahnen-Dechent; Uyen Huynh-Do
Journal:  Pflugers Arch       Date:  2022-04-11       Impact factor: 4.458

3.  Negative energy balance alters global gene expression and immune responses in the uterus of postpartum dairy cows.

Authors:  D Claire Wathes; Zhangrui Cheng; Waliul Chowdhury; Mark A Fenwick; Richard Fitzpatrick; Dermot G Morris; Joe Patton; John J Murphy
Journal:  Physiol Genomics       Date:  2009-06-30       Impact factor: 3.107

4.  Influence of energy balance on the somatotrophic axis and matrix metalloproteinase expression in the endometrium of the postpartum dairy cow.

Authors:  D Claire Wathes; Zhangrui Cheng; Mark A Fenwick; Richard Fitzpatrick; Joe Patton
Journal:  Reproduction       Date:  2010-12-01       Impact factor: 3.906

5.  Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.

Authors:  Konstantin Karmilin; Carlo Schmitz; Michael Kuske; Hagen Körschgen; Mario Olf; Katharina Meyer; André Hildebrand; Matthias Felten; Sven Fridrich; Irene Yiallouros; Christoph Becker-Pauly; Ralf Weiskirchen; Willi Jahnen-Dechent; Julia Floehr; Walter Stöcker
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

6.  Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes.

Authors:  Pedro Magalhães; Petra Zürbig; Harald Mischak; Erwin Schleicher
Journal:  Clin Kidney J       Date:  2020-10-23

7.  Selective enrichment of sialylated glycopeptides with a d-allose@SiO2 matrix.

Authors:  Na Sun; Yuting Xiong; Guangyan Qing; Yanyan Zhao; Xiuling Li; Xinmiao Liang
Journal:  RSC Adv       Date:  2018-11-19       Impact factor: 4.036

Review 8.  The structure, biosynthesis, and biological roles of fetuin-A: A review.

Authors:  Endeshaw Chekol Abebe; Zelalem Tilahun Muche; Awigchew Behaile T/Mariam; Teklie Mengie Ayele; Melaku Mekonnen Agidew; Muluken Teshome Azezew; Edgeit Abebe Zewde; Tadesse Asmamaw Dejenie; Misganaw Asmamaw Mengstie
Journal:  Front Cell Dev Biol       Date:  2022-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.